Intravitreal Ocriplasmin in a Sentence

Manuscript Generator

Learn more from Intravitreal Ocriplasmin

More Intravitreal Ocriplasmin sentence examples

10.1136/bjophthalmol-2019-314142

This report quantitatively analysed outer retinal changes after intravitreal ocriplasmin.

Longitudinal ellipsoid zone and subretinal fluid mapping following ocriplasmin injection in the prospective observational ORBIT trial

10.1097/IAE.0000000000002116

METHODS This consecutive, retrospective study included 24 patients (29 eyes) who experienced vitreomacular traction release with pneumatic vitreolysis (n = 9), intravitreal ocriplasmin (n = 6), or pars plana vitrectomy (n = 14).

SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FINDINGS AND VISUAL OUTCOME AFTER TREATMENT FOR VITREOMACULAR TRACTION.

10.1186/s12886-019-1119-9

MethodsIn this pilot study, we enrolled sixteen VMT eyes treated with intravitreal ocriplasmin injection.

Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction

Discover more insights into Intravitreal Ocriplasmin

Keywords frequently search together with Intravitreal Ocriplasmin

Narrow sentence examples with built-in keyword filters

10.1007/s10792-019-01177-7

Purpose To describe and analyze short-term posterior vitreous abnormalities following intravitreal ocriplasmin in eyes with symptomatic vitreomacular traction syndrome (VMT).

Short-term changes in posterior vitreous cortex following intravitreal ocriplasmin for symptomatic vitreomacular traction syndrome: a prospective study

10.26715/jbms.31_23062019

Subfoveal fluid is a well-known side effect of intravitreal ocriplasmin, mostly resolving spontaneously and completely over a period of few months.

Neurosensory Macular Retinal Detachment after Intravitreal Ocriplasmin Treated Successfully with Oral Carbonic Anhydrase Inhibitor

10.3760/CMA.J.ISSN.1673-5803.2019.02.006

As the second-generation enzymatic agents, the efficacy of intravitreal ocriplasmin for both vitreomacular traction (VMT) syndrome and full-thickness macular hole (FTMH) is better than MIVI-TRUST(microplasmin for intravitreous injection-traction release without surgical treatment) trial.

Research advances of pharmacological vitreolysis

Learn more from Intravitreal Ocriplasmin

An Overview of Intravitreal Ocriplasmin

Intravitreal Ocriplasmin
Encyclopedia

What is/are Intravitreal Ocriplasmin?

Intravitreal Ocriplasmin - This report quantitatively analysed outer retinal changes after intravitreal ocriplasmin. [1] METHODS This consecutive, retrospective study included 24 patients (29 eyes) who experienced vitreomacular traction release with pneumatic vitreolysis (n = 9), intravitreal ocriplasmin (n = 6), or pars plana vitrectomy (n = 14). [2] MethodsIn this pilot study, we enrolled sixteen VMT eyes treated with intravitreal ocriplasmin injection. [3] Purpose To describe and analyze short-term posterior vitreous abnormalities following intravitreal ocriplasmin in eyes with symptomatic vitreomacular traction syndrome (VMT). [4] Subfoveal fluid is a well-known side effect of intravitreal ocriplasmin, mostly resolving spontaneously and completely over a period of few months. [5] As the second-generation enzymatic agents, the efficacy of intravitreal ocriplasmin for both vitreomacular traction (VMT) syndrome and full-thickness macular hole (FTMH) is better than MIVI-TRUST(microplasmin for intravitreous injection-traction release without surgical treatment) trial. [6]